SLRX - Salarius Pharmaceuticals, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - SLRX (1615219)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
9 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2022-06-07
SLRXBurleson TessDirP - Purchase$0.18+27,70032,050+637%+$4,986
2022-06-07
SLRXLieber Jonathan IDirP - Purchase$0.19+37,50037,500New+$7,016
2022-06-06
SLRXMcVicar William K.DirP - Purchase$0.19+26,55326,553New+$5,000
2022-06-03
SLRXHanish Arnold CDirP - Purchase$0.18+28,00046,350+153%+$5,152
A
2020-08-21
SLRXHanish Arnold CDirP - Purchase$0.98+4,00011,350+54%+$3,920
A
2020-02-11
SLRXHanish Arnold CDirP - Purchase$1.15+4,3507,350+145%+$5,003
A
2019-11-25
SLRXHanish Arnold CDirP - Purchase$3.59+3,0003,000New+$10,770
2022-05-26
SLRXArthur David J.CEOP - Purchase$0.18+43,900878,022+5%+$7,985
2022-05-31
SLRXRosenblum Mark JEVP Finance, CFOP - Purchase$0.18+28,000148,319+23%+$5,040

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top